DGAP-News: MediClin AG: Business development of MediClin in FY 2010
(firmenpresse) - DGAP-News: MediClin AG / Key word(s): Final Results
MediClin AG: Business development of MediClin in FY 2010
24.03.2011 / 08:30
---------------------------------------------------------------------
Frankfurt am Main, March 24, 2011 - The Management Board of MEDICLIN
Aktiengesellschaft (MediClin) said at this year's balance sheet press
conference that he is satisfied with the results of the year 2010. 'We have
reached our internal growth target of plus 3.0 % per year. Sales rose by
3.5 %, or by EUR 16.6 mill. as compared to the previous year up to EUR
487.2 mill. ', said Dr. Ulrich Wandschneider, CEO of MediClin. In the
post-acute segment, sales increased by
1.9 %, from EUR 270.0 mill. to EUR 275.2 mill. In the acute segment, sales
rose even stronger, namely by 5.6 % or EUR 10.7 mill. to EUR 200.3 mill.
The Management Board was also satisfied with the sales development of the
outpatient services and the medical care centres. In 2010, sales from
outpatient services rose by EUR 4.4 mill. to EUR 16.3 mill., which
constitutes 3.3 % of the consolidated sales revenues. Of this sum,
approximately EUR 6.9 mill. (2009: EUR 3.2 mill.) was attributable to the
medical care centres.
The consolidated operating result did not rise. At EUR 16.9 mill., it is
just under the 2009 result (2009: EUR 17.0 mill.). The result was primarily
affected by higher maintenance costs as compared to the previous year, as
well as higher personnel costs due to personnel recruitment. In terms of
the segments, the post-acute segment result of EUR 6.2 mill. was on a par
with the previous year. The acute segment result improved in relation to
the previous year, totalling EUR 18.1 mill. The EBIT margins are 2.2 % and
9.1 %, respectively.
Proposal of a dividend payment
As business development in 2010 was satisfactory, and the Management Board
foresee stable economic environment as well as a stable labour market in
2011, the Management Board and the Supervisory Board will propose a
dividend of EUR 0.05 per share for the 2010 financial year at the Annual
General Meeting on 26 May 2011.
Outlook
MediClin will again invest in internal growth in 2011, and, as long as
framework conditions in the industry and the referral practices of coverage
providers do not change drastically, the Management Board anticipates a
slight increase in sales and a result on the previous year's level.
The annual report 2010 is available under www.mediclin.de in German und
English.
About MediClin AG (Ticker: MED; ISIN: DE0006595101)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neurosciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungszentren (medical care units) in 11 federal states MediClin has a
total capacity of approximately 8,000 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,100 employees.
Important notice:
This press release includes future-oriented statements which are based on
assumptions and estimates. While MediClin AG is of the opinion that these
assumptions and estimates are correct, the actual future developments and
actual future results may deviate from these assumptions and estimates due
to the impact of various factors such aschanges in the economic conditions
in Germany, legal changes concerning the health system, changes relating to
cost providers' expense behaviour. MediClin does not assume liability and
gives no warranty that future developments and the income actually achieved
in the future will comply with the assumptions and estimates stated in this
press release.
End of Corporate News
---------------------------------------------------------------------
24.03.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Deutschland
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr(at)mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
116763 24.03.2011
Datum: 24.03.2011 - 08:30 Uhr
Sprache: Deutsch
News-ID 33564
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 259 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MediClin AG: Business development of MediClin in FY 2010"
steht unter der journalistisch-redaktionellen Verantwortung von
MediClin AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
